TICAGRELOR for Coronary artery disease: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 520 adverse event reports in the FDA FAERS database where TICAGRELOR was used for Coronary artery disease.
Most Reported Side Effects for TICAGRELOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 3,156 | 13.8% | 74 | 1,089 |
| Myocardial infarction | 1,749 | 7.6% | 129 | 872 |
| Death | 1,510 | 6.6% | 1,510 | 108 |
| Off label use | 1,084 | 4.7% | 51 | 476 |
| Fatigue | 1,081 | 4.7% | 16 | 280 |
| Chest pain | 1,075 | 4.7% | 42 | 623 |
| Contusion | 970 | 4.2% | 11 | 263 |
| Dizziness | 811 | 3.5% | 10 | 308 |
| Vascular stent thrombosis | 700 | 3.1% | 66 | 345 |
| Haemorrhage | 676 | 3.0% | 78 | 233 |
| Malaise | 647 | 2.8% | 17 | 175 |
| Epistaxis | 624 | 2.7% | 21 | 240 |
| Chest discomfort | 620 | 2.7% | 4 | 236 |
| Asthenia | 617 | 2.7% | 10 | 241 |
| Anaemia | 600 | 2.6% | 38 | 441 |
Other Indications for TICAGRELOR
Acute coronary syndrome (4,530)
Stent placement (3,424)
Myocardial infarction (2,988)
Product used for unknown indication (1,491)
Acute myocardial infarction (1,312)
Antiplatelet therapy (660)
Thrombosis prophylaxis (524)
Cardiovascular event prophylaxis (351)
Anticoagulant therapy (305)
Percutaneous coronary intervention (297)
Other Drugs Used for Coronary artery disease
ASPIRIN (2,758)
CLOPIDOGREL BISULFATE (1,584)
EVOLOCUMAB (1,266)
ATORVASTATIN (891)
RIVAROXABAN (847)
DILTIAZEM (664)
ROSUVASTATIN (600)
QUINAPRIL (511)
AMLODIPINE (486)
NITROGLYCERIN (421)